Necrotizing Gingivostomatitis Treatment Market Analysis

  • Report ID: 3570
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Necrotizing Gingivostomatitis Treatment Market Analysis

Type {Necrotizing Ulcerative Gingivitis (NUG), Necrotizing Ulcerative Periodontitis (NUP), Necrotizing Stomatitis (NS)}

The global necrotizing gingivostomatitis treatment market is segmented and analyzed for demand and supply by type into necrotizing ulcerative gingivitis (NUG), necrotizing ulcerative periodontitis (NUP), and necrotizing stomatitis (NS). Out of the three types, the necrotizing ulcerative periodontitis segment is estimated to gain the largest market share of about 38% in the year 2036. The growth of the segment can be attributed to the increasing number of people who smoke regularly across the world. The growing stress, anxiety, and sleep deprivation are also estimated to rise the market growth. Over 75% of people across the U.S. are estimated to feel stress that causes physical illness as of 2022 reports. The use of antiseptic mouthwashes or oral antibiotics is used for the treatment of necrotizing ulcerative periodontitis. The practice of oral hygiene with oral medication and proper diet is believed to help during the recovery time of patients. The increasing consumption of antibiotics by most people across the globe as the first line of drug therapy is anticipated to drive market segment growth in the coming years. The list of antibiotics that are used in the treatment procedure includes amoxicillin, metronidazole, clavulanate, tetracyclines, and penicillins. The lack of awareness about hygienic practices and not maintaining any routine to prevent gum diseases is also estimated to fuel the growth of the market segment.

Treatment (Antiseptic Rinses, Antibiotics, Gingival Grafting)

The global necrotizing gingivostomatitis treatment market is also segmented and analyzed for demand and supply by treatment into antiseptic rinses, antibiotics, gingival grafting, and others. Amongst these segments, the antiseptic rinses segment is expected to garner a significant share of around 32% in the year 2036. The Increasing number of cases of drinking alcohol and chewing tobacco or smoking is estimated to drive the market growth. The use of antiseptic rinses is the best way to prevent or reduce the infection as it cleanses the bacteria grown on the surface without worsening further. The antiseptic rinses after brushing and eating remove harmful bacteria or microorganisms cleaning the area of infected gums. Antiseptic rinses help to regulate the formation of plaque and disrupt the bacteria in the mouth.

Our in-depth analysis of the global market includes the following segments:

     By Type

  • Necrotizing Ulcerative Gingivitis (NUG)
  • Necrotizing Ulcerative Periodontitis (NUP)
  • Necrotizing Stomatitis (NS)

 

   By Treatment

  • Antiseptic Rinses
  • Antibiotics
  • Gingival Grafting
  • Others

 

    By Distribution Channel

  • Hospital Pharmacies
  • Medical Store
  • Online
  • Others

 

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3570
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of necrotizing gingivostomatitis treatment is estimated at USD 16.94 Million.

The necrotizing gingivostomatitis treatment market size was valued at USD 15.99 Million in 2023 and is anticipated to cross USD 36.7 Million by the end of 2036, expanding at more than 6.6% CAGR during the forecast period i.e., between 2024-2036. Increasing incidences of necrotizing gingivostomatitis and the rising use of public toilets are the major factors driving the market growth.

North America is poised to be the largest with a share of about 39% by 2036, attributed to high prevalence of lifestyle diseases, caused by inactive routines, busy lifestyles, and unhealthy eating habits.

Novartis International AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Eli Lilly and Company, Hindustan Antibiotics Limited, Aviro Health L.P.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample